SPDR Series Trust - State Street SPDR S&P Biotech ETF
US ˙ ARCA ˙ US78464A8707

SecurityXBI / SPDR Series Trust - State Street SPDR S&P Biotech ETF
InstitutionTocqueville Asset Management L.p.
Latest Disclosed Ownership83,906 shares
Latest Disclosed Value $ 10,717,313
Tocqueville Asset Management L.p. reports 0.95% decrease in ownership of XBI / SPDR Series Trust - State Street SPDR S&P Biotech ETF

On May 12, 2026 - Tocqueville Asset Management L.p. filed a 13F-HR form disclosing ownership of 83,906 shares of SPDR Series Trust - State Street SPDR S&P Biotech ETF (US:XBI) valued at $10,717,313 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 84,715 shares of SPDR Series Trust - State Street SPDR S&P Biotech ETF. This represents a change in shares of -0.95% during the quarter. The current value of the position is $10,796,185 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F SPDR SERIES TRUST STATE STREET SPD 78464A870 83,906 -809 -0.95 10,717 3.76 0.1589
2026-02-12 2025-12-31 13F SPDR SERIES TRUST STATE STREET SPD 78464A870 84,715 -125 -0.15 10,329 21.52 0.1507
2025-11-13 2025-09-30 13F SPDR SERIES TRUST S&P BIOTECH 78464A870 84,840 -146 -0.17 8,501 20.62 0.1236
2025-08-12 2025-06-30 13F SPDR SERIES TRUST S&P BIOTECH 78464A870 84,986 -10,244 -10.76 7,048 -8.75 0.1073
2025-05-13 2025-03-31 13F SPDR SER TR S&P BIOTECH 78464A870 95,230 27,020 39.61 7,723 25.72 0.1261
2025-02-10 2024-12-31 13F SPDR SER TR S&P BIOTECH 78464A870 68,210 -5,259 -7.16 6,143 -15.36 0.0963
2024-11-08 2024-09-30 13F SPDR SER TR S&P BIOTECH 78464A870 73,469 -21,848 -22.92 7,259 -17.86 0.1140
2024-08-12 2024-06-30 13F SPDR SER TR S&P BIOTECH 78464A870 95,317 -3,567 -3.61 8,837 -5.83 0.1459
2024-05-09 2024-03-31 13F SPDR SER TR S&P BIOTECH 78464A870 98,884 5 0.01 9,383 6.29 0.1533
2024-02-12 2023-12-31 13F SPDR SER TR S&P BIOTECH 78464A870 98,879 -2,096 -2.08 8,829 19.73 0.1600
2023-11-09 2023-09-30 13F SPDR SER TR S&P BIOTECH 78464A870 100,975 -39 -0.04 7,373 -12.27 0.1400
2023-08-11 2023-06-30 13F SPDR SER TR S&P BIOTECH 78464A870 101,014 -13,422 -11.73 8,404 -3.63 0.1505
2023-05-10 2023-03-31 13F SPDR SER TR S&P BIOTECH 78464A870 114,436 1,670 1.48 8,721 -6.82 0.1648
2023-02-09 2022-12-31 13F SPDR SER TR S&P BIOTECH 78464A870 112,766 -1,535 -1.34 9,360 3.23 0.1778
2022-11-10 2022-09-30 13F SPDR SER TR S&P BIOTECH 78464A870 114,301 -5,159 -4.32 9,066 2.19 0.1848
2022-08-12 2022-06-30 13F SPDR SER TR S&P BIOTECH 78464A870 119,460 4,489 3.90 8,872 -14.15 0.1622
2022-05-16 2022-03-31 13F SPDR Series Trust S&P Biotech COM 78464A870 114,971 23,475 25.66 10,334 0.88 0.1561
2022-02-14 2021-12-31 13F SPDR SER TR S&P BIOTECH 78464A870 91,496 13,141 16.77 10,244 4.00 0.1409
2021-11-15 2021-09-30 13F SPDR SER TR S&P BIOTECH 78464A870 78,355 13,151 20.17 9,850 11.56 0.1459
2021-08-16 2021-06-30 13F SPDR SER TR S&P BIOTECH 78464A870 65,204 18,354 39.18 8,829 38.93 0.1276
2021-05-17 2021-03-31 13F SPDR SER TR S&P BIOTECH 78464A870 46,850 700 1.52 6,355 -2.19 0.0978
2021-02-16 2020-12-31 13F SPDR SER TR S&P BIOTECH 78464A870 46,150 -70 -0.15 6,497 26.16 0.1085
2020-11-16 2020-09-30 13F SPDR S&P BIOTECH ETF COM 78464A870 46,220 -75,000 -61.87 5,150 -62.05 0.0985
2020-08-12 2020-06-30 13F SPDR SER TR S&P BIOTECH 78464A870 121,220 -24,845 -17.01 13,571 19.98 0.2830
2020-05-15 2020-03-31 13F SPDR SER TR COM 78464A870 146,065 -7,615 -4.96 11,311 -22.62 0.2810
2020-01-14 2019-12-31 13F SPDR S&P Biotech ETF COM 78464A870 153,680 8,010 5.50 14,617 31.60 0.2150
2019-10-31 2019-09-30 13F SPDR S&P Biotech ETF COM 78464A870 145,670 9,550 7.02 11,107 -6.97 0.1507
2019-07-31 2019-06-30 13F SPDR S&P Biotech ETF COM 78464A870 136,120 -80 -0.06 11,939 -3.19 0.1547
2019-04-30 2019-03-31 13F SPDR S&P Biotech ETF COM 78464A870 136,200 -13,390 -8.95 12,332 14.90 0.1646
2019-02-08 2018-12-31 13F SPDR S&P Biotech ETF COM 78464A870 149,590 58,960 65.06 10,733 23.52 0.1608
2018-11-13 2018-09-30 13F SPDR S&P Biotech ETF COM 78464A870 90,630 2,535 2.88 8,689 3.61 0.1095
2018-08-13 2018-06-30 13F SPDR S&P Biotech ETF COM 78464A870 88,095 -4,800 -5.17 8,386 2.90 0.1064
2018-05-14 2018-03-31 13F SPDR S&P Biotech ETF COM 78464A870 92,895 70,255 310.31 8,150 324.26 0.1038
2018-02-13 2017-12-31 13F SPDR S&P Biotech ETF COM 78464A870 22,640 750 3.43 1,921 1.37 0.0218
2017-10-30 2017-09-30 13F SPDR S&P Biotech ETF COM 78464A870 21,890 300 1.39 1,895 13.75 0.0218
2017-08-04 2017-06-30 13F SPDR S&P Biotech ETF COM 78464A870 21,590 5,450 33.77 1,666 48.88 0.0200
2017-04-28 2017-03-31 13F SPDR S&P Biotech ETF COM 78464A870 16,140 354 2.24 1,119 19.81 0.0137
2017-01-30 2016-12-31 13F SPDR S&P Biotech ETF COM 78464A870 15,786 -2,044 -11.46 934 -20.98 0.0119
2016-10-31 2016-09-30 13F SPDR S&P Biotech ETF COM 78464A870 17,830 -110 -0.61 1,182 21.86 0.0142
2016-08-15 2016-06-30 13F/A-1 SPDR S&P Biotech ETF COM 78464A870 17,940 0 0.00 970 4.64 0.0116
2016-07-29 2016-06-30 13F SPDR S&P Biotech ETF COM 78464A870 17,940 970
2016-04-29 2016-03-31 13F SPDR S&P Biotech ETF COM 78464A870 17,940 0 0.00 927 -26.37 0.0123
2016-01-29 2015-12-31 13F SPDR S&P Biotech ETF COM 78464A870 17,940 -675 -3.63 1,259 8.63 0.0171
2015-10-30 2015-09-30 13F SPDR S&P Biotech ETF COM 78464A870 18,615 12,410 200.00 1,159 -25.94 0.0155
2015-07-31 2015-06-30 13F SPDR S&P Biotech ETF COM 78464A870 6,205 -65 -1.04 1,565 10.68 0.0184
2015-04-30 2015-03-31 13F SPDR S&P Biotech ETF COM 78464A870 6,270 6,270 0.00 1,414 0.0166
2014-10-30 2014-09-30 13F SPDR S&P Biotech ETF COM 78464A870 0 -17,335 -100.00 0 -100.00
2014-09-18 2014-06-30 13F/A-1 SPDR S&P Biotech ETF COM 78464A870 17,335 17,335 -42.94 2,669 -31.98 0.0260
2014-07-30 2014-06-30 13F SPDR S&P Biotech ETF COM 78464A870 17,335 2,669
2014-01-30 2013-12-31 13F SPDR S&P Biotech ETF COM 78464A870 0 -30,380 -100.00 0 -100.00
2013-10-30 2013-09-30 13F SPDR S&P Biotech ETF COM 78464A870 30,380 -5,045 -14.24 3,924 6.26 0.0489
2013-07-30 2013-06-30 13F SPDR S&P Biotech ETF COM 78464A870 35,425 35,425 3,693 0.0500
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.